John Vavricka

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Boston, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Andrea Corcoran, as Attorney-in-Fact for John Vavricka
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for John Vavricka

Form 4 holding Chief Commercial Officer

Atea Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
82,508
Estimated value
$294,553
Report date
31 Jan 2026
Price
$3.57
Ownership
Held by John Vavricka as the Trustee of the John F. Vavricka Deed of Trust
Form 4 holding Chief Commercial Officer

Atea Pharmaceuticals, Inc.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
$26,775
Report date
31 Jan 2026
Price
$3.06
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Commercial Officer

Atea Pharmaceuticals, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
119,520
Estimated value
Report date
31 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by John Vavricka

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .